Access cutting-edge multiple myeloma (mm) treatment through this clinical trial at a research site in Maywood. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Maywood location
Preparing your pre-screening questions…
Access multiple myeloma (mm) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma (mm) treatment provided free
Check if you qualify for this multiple myeloma (mm) clinical trial in Maywood, IL
No-Cost Study Care
Local to Maywood
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The main purpose of the study is to understand the safety and tolerability of cemsidomide when given along with elranatamab in subjects with relapsed or refractory multiple myeloma. The first part of the study will evaluate different dose levels of cemsidomide in combination with elranatamab in a limited number of subjects. Approximately 3 different dose levels of cemsidomide in combination with elranatamab may be explored. Once a dose level is determined safe, additional subjects may be enrolled through expansion of the dose level. This expansion will provide further exploration of the safety and evaluation of preliminary antimyeloma activity. Cemsidomide will be taken orally each cycle for 14 days on/14 days off (1 cycle=28 days). Elranatamab will be administered by subcutaneous injection twice a month. Dexamethasone will be administered weekly until a confirmed response but no longer than 4 cycles.
Sponsor: C4 Therapeutics, Inc.
Yes, this clinical trial (NCT07280013) has an active research site in Maywood, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for multiple myeloma (mm) treatment options in Maywood, IL, this clinical trial (NCT07280013) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Maywood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma (mm) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all multiple myeloma (mm) clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Maywood — not just this study.
Browse Multiple Myeloma Trials in Maywood →